Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
December 1, 2025Cancer Epidemiology Biomarkers & Prevention

Prevalence of rare cancer survivors in the United States

View Full Paper
Ask AI
Bookmark
Share

Authors

LGLisa GallicchioTDTheresa P. DevasiaAMAngela B. Mariotto

Discussion

Loading...

Member takes

Overview

Analysis estimates over 4.9 million rare cancer survivors in the US, suggesting significant unmet survivorship needs.

Key Points

  • Nearly 5 million individuals are survivors with rare cancer diagnoses in the US, indicating a large population.
  • Approximately 69.9% of rare cancer survivors are long-term survivors, with 49.5% classified as very long-term survivors.
  • Data was analyzed from the Surveillance, Epidemiology, and End Results program with joinpoint regression models applied.
  • Findings underline the importance of addressing the unique survivorship needs of rare cancer survivors.

Cite This Study

Gallicchio et al. (2025) studied this question.

synapsesocial.com/papers/69402c4d2d562116f290296fhttps://doi.org/10.1158/1055-9965.epi-25-1196
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Prevalence of rare cancer survivors in the United States2025
  2. 2Prevalence of cancer survivors in the United States2024 · 281 citations
  3. 3Patients with rare cancers: Diagnosis and treatment patterns in the US.2025
  4. 4Closing the Gaps: Addressing the Unmet Needs of Cancer Survivors2024
  5. 5Pediatric cancer survival in the United States from 2001 to 20212026 · 1 citations